Floatz logo

Letrozole

Diffuse Hemispheric Glioma, H3 G34-Mutant

Nationwide Children's HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

10 Active assets in the Diffuse Hemispheric Glioma, H3 G34-Mutant cohort.

Asset / SponsorPhaseRating
Ribociclib
Nationwide Children's Hospital
Phase 2CCC
LEUPROLIDE
Nationwide Children's Hospital
Phase 2CCC
Everolimus
Nationwide Children's Hospital
Phase 2CCC
FULVESTRANT
Nationwide Children's Hospital
Phase 2CCC
Zoladex
Nationwide Children's Hospital
Phase 2CCC

View all 10 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →